Utilizzo di sacituzumab govitecan nel carcinoma mammario metastatico HR+/HER2- dopo progressione a terapia endocrina e chemioterapia: descrizione di un caso clinico in accordo con i risultati dello studio TROPiCS-02

Raffaella Ruocco, Roberto Esposito, Giovanni Fiore, Carmen Mocerino

Open source

DOI: 10.1701/4764.47850
Published: 2026-09-01
Container: Recenti Progressi in Medicina
Publisher: Il Pensiero Scientifico Editore
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1701/4764.47850,
  title = {Utilizzo di sacituzumab govitecan nel carcinoma mammario metastatico HR+/HER2- dopo progressione a terapia endocrina e chemioterapia: descrizione di un caso clinico in accordo con i risultati dello studio TROPiCS-02},
  author = {Raffaella Ruocco and Roberto Esposito and Giovanni Fiore and Carmen Mocerino},
  year = {2026},
  journal = {Recenti Progressi in Medicina},
  doi = {10.1701/4764.47850},
  url = {https://doi.org/10.1701/4764.47850}
}

RIS

TY  - JOUR
TI  - Utilizzo di sacituzumab govitecan nel carcinoma mammario metastatico HR+/HER2- dopo progressione a terapia endocrina e chemioterapia: descrizione di un caso clinico in accordo con i risultati dello studio TROPiCS-02
AU  - Raffaella Ruocco
AU  - Roberto Esposito
AU  - Giovanni Fiore
AU  - Carmen Mocerino
PY  - 2026
JO  - Recenti Progressi in Medicina
DO  - 10.1701/4764.47850
UR  - https://doi.org/10.1701/4764.47850
ER  -

APA

Ruocco, R., Esposito, R., Fiore, G., & Mocerino, C. (2026). Utilizzo di sacituzumab govitecan nel carcinoma mammario metastatico HR+/HER2- dopo progressione a terapia endocrina e chemioterapia: descrizione di un caso clinico in accordo con i risultati dello studio TROPiCS-02. Recenti Progressi in Medicina. https://doi.org/10.1701/4764.47850

Source records

crossref · retrieved 2026-09-24T23:39:48.888Z